We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$74.2M
(+40%)
Cap. Flow
+$60.4M
Cap. Flow
% of AUM
23.06%
Top 10 Holdings %
Top 10 Hldgs %
27.97%
Holding
236
New
148
Increased
23
Reduced
45
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$8.58M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$7.26M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$5.88M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$4.5M |
| 5 |
Visa
V
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$4.78M |
| 2 |
Novartis
NVS
|
+$4.73M |
| 3 |
Citigroup
C
|
+$3.89M |
| 4 |
Enterprise Products Partners
EPD
|
+$3.74M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Technology | 18.17% |
| 3 | Financials | 14.51% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Energy | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dollar Tree
DLTR
$23.1B
| $153K | 0.06% |
+1,800
| New | +$166K |
|
|
DERM
177
DELISTED
Dermira, Inc.
DERM
| $153K | 0.06% |
+16,700
| New | +$156K |
|
178
Union Pacific
UNP
$182B
| $142K | 0.05% |
+1,000
| New | +$139K |
|
|
CCXI
179
DELISTED
ChemoCentryx, Inc.
CCXI
| $132K | 0.05% |
+10,000
| New | +$120K |
|
180
Hershey
HSY
$35.4B
| $130K | 0.05% |
+1,400
| New | +$131K |
|
181
Cirrus Logic
CRUS
$6.74B
| $115K | 0.04% |
+3,000
| New | +$115K |
|
182
LivaNova
LIVN
$4.3B
| $100K | 0.04% |
+1,000
| New | +$90.8K |
|
183
Danaher
DHR
$135B
| $99K | 0.04% |
+1,128
| New | +$100K |
|
|
ARRS
184
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $98K | 0.04% |
+4,000
| New | +$105K |
|
185
Waters Corp
WAT
$36.8B
| $97K | 0.04% |
+500
| New | +$98.5K |
|
186
Advance Auto Parts
AAP
$3.37B
| $94K | 0.04% |
+700
| New | +$85.1K |
|
187
Larimar Therapeutics
LRMR
$416M
| $93K | 0.04% |
+760
| New | +$64.6K |
|
188
Jazz Pharmaceuticals
JAZZ
$15.9B
| $86K | 0.03% |
+500
| New | +$81.7K |
|
189
SLB Ltd
SLB
$78.4B
| $80K | 0.03% |
+1,200
| New | +$82.4K |
|
|
PX
190
DELISTED
Praxair Inc
PX
| $79K | 0.03% |
+500
| New | +$77.3K |
|
191
MPLX
MPLX
$59.5B
| $78K | 0.03% |
+2,289
| New | +$79.6K |
|
192
Norfolk Southern
NSC
$78.8B
| $75K | 0.03% |
500
-13,924
| -97% | -$2.03M |
|
193
eBay
EBAY
$48.6B
| $73K | 0.03% |
2,000
-48,201
| -96% | -$1.88M |
|
194
PepsiCo
PEP
$186B
| $71K | 0.03% |
+650
| New | +$67.1K |
|
195
Coca-Cola
KO
$354B
| $67K | 0.03% |
+1,520
| New | +$65.7K |
|
196
Healthpeak Properties
DOC
$15.4B
| $64K | 0.02% |
+2,476
| New | +$58.4K |
|
|
CELG
197
DELISTED
Celgene Corp
CELG
| $64K | 0.02% |
+800
| New | +$66.4K |
|
198
Chevron
CVX
$388B
| $63K | 0.02% |
+500
| New | +$62.1K |
|
199
Colgate-Palmolive
CL
$72.6B
| $58K | 0.02% |
+900
| New | +$58.9K |
|
200
EQT Corp
EQT
$33.2B
| $58K | 0.02% |
+1,929
| New | +$53.8K |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Grace Capital held 236 positions worth $262M, up 40% from $188M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Grace Capital deployed $60.4M of net new capital in Q2 2018, opening 148 new positions and adding to 23 existing holdings. Its largest new stake was MyoKardia, Inc. Common Stock: 177,304 shares worth $8.8M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Citigroup, an estimated $3.89M trimmed.
- Grace Capital's largest Q2 2018 buy was MyoKardia, Inc. Common Stock: 177,304 shares worth $8.8M.
- Grace Capital added most to Meta Platforms (Facebook) in Q2 2018, an estimated $2.91M increase.
- Grace Capital's biggest Q2 2018 reduction was Citigroup, cutting an estimated $3.89M.
- Grace Capital fully exited Check Point Software Technologies in Q2 2018, selling an estimated $4.78M.
- Grace Capital's ten largest holdings make up 28% of its $262M portfolio in Q2 2018.
- Grace Capital opened 148 new positions and closed 16 in Q2 2018.
- Grace Capital's portfolio value rose 40% quarter-over-quarter to $262M.
Based on Grace Capital's 13F filing for Q2 2018, filed 15 Aug 2018.